Search

everythinglearnresearchcommunity

for

Search:↓

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Different hair care practices and conditions affect African American hair and scalp health, requiring specialized knowledge for treatment.

Insulin resistance linked to obesity may increase COVID-19 severity.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Male cancer patients have a higher risk of severe illness and death from COVID-19 than female patients.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Men, diabetes, and high inflammation levels lead to higher COVID-19 antibodies.

The COVID-19 pandemic led to fewer dermatology visits and changed the types of skin conditions patients experienced.

Wait 3 months after COVID-19 before trying assisted reproduction and further research is needed on COVID-19's effects on male hormones and fertility.

Children with HIV often have skin problems that can indicate the severity of their immune system damage.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Hair analysis can show nutritional status and environmental exposure, with phosphorus being very stable in hair and differences found based on gender and conditions like depression and autism.

The conclusion is that certain genetic factors and blood types may affect COVID-19 severity, but changes in ACE2 and TMPRSS2 genes are not clearly linked to it.

COVID-19 changed dermatology by increasing telemedicine and highlighting healthcare disparities.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

The research suggests Dutasteride and Solifenacin may be effective against the bacterium causing listeriosis.

Sex hormones like estrogen and testosterone may affect COVID-19 severity differently in men and women, potentially influencing prevention and treatment strategies.

Gloriosa superba poisoning can mimic severe tropical infections and cause rapid hair loss.

People with lower levels of free testosterone tend to have worse COVID-19 outcomes.

The COVID-19 pandemic caused most hair transplant surgeons in India to stop working, and many planned to change their safety measures afterwards.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Thallium, mercury, selenium, and colchicine strongly cause hair loss.

New treatments like nanotechnology show promise in improving skin cancer therapy.

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

Men with androgenetic alopecia and hypertension may experience more severe COVID-19.

The convention discussed various skin conditions and treatments, and highlighted the importance of vaccinations for patients on immune-altering medications.

COVID-19 can cause temporary hair loss due to stress and inflammation.